A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Pulmonary blastoma (PB) is a rare aggressive lung malignancy with a poor prognosis. Surgical resection is the treatment of choice for localized disease, and there are no standard treatment guidelines for metastatic PB. Due to its rareness, its molecular profile has not been elucidated. We present th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Meng, Zhaoting, Chen, Peng, Zang, Fenglin, Liu, Ying, Xu, Xiaoyan, Su, Yudong, Chen, Jinliang, Lin, Li, Zhang, Lu, Zhang, Tengfei
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749379/
https://ncbi.nlm.nih.gov/pubmed/29343973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S150001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados